XBiotech Historical Balance Sheet

XBIT Stock

USD 7.35 0.54 7.93%

Trend analysis of XBiotech balance sheet accounts such as Total Assets of 209.4 M, Short Long Term Debt Total of 800, Other Current Liabilities of 6.5 M or Total Current Liabilities of 9.4 M provides information on XBiotech's total assets, liabilities, and equity, which is the actual value of XBiotech to its prevalent stockholders. By breaking down trends over time using XBiotech balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining XBiotech latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether XBiotech is a good buy for the upcoming year.

XBiotech Inventory

(7.65 Million)

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.

About XBiotech Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of XBiotech at a specified time, usually calculated after every quarter, six months, or one year. XBiotech Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of XBiotech and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which XBiotech currently owns. An asset can also be divided into two categories, current and non-current.

XBiotech Balance Sheet Chart

At this time, XBiotech's Other Current Liabilities is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 9.4 M in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 22.6 M in 2024.

Total Assets Short Long Term Debt Total Total Liab Common Stock Long Term Debt Additional Paid In Capital

Add Fundamental

Total Assets

Total assets refers to the total amount of XBiotech assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in XBiotech books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Long Term Debt

Long-term debt is a debt that XBiotech has held for over one year. Long-term debt appears on XBiotech balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on XBiotech balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Additional Paid In Capital

Additional Paid In Capital (or APIC) is an accounting term found on XBiotech Balance Sheet under Shareholders Equity. It is the value of the shares of the company above what they were issued it. The basic calculation is as follow: (Issue Price - Par Value) x XBiotech Shares Outstanding. Additional Paid In Capital is not affected by secondary trading of XBiotech shares and does not have any impact on the value of APIC. The excess amount paid by investors over the par value of a company's shares, representing the additional capital contributed by shareholders.

Most accounts from XBiotech's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into XBiotech current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in XBiotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For more information on how to buy XBiotech Stock please use our How to Invest in XBiotech guide.At this time, XBiotech's Other Current Liabilities is comparatively stable compared to the past year. Total Current Liabilities is likely to gain to about 9.4 M in 2024, whereas Property Plant And Equipment Net is likely to drop slightly above 22.6 M in 2024.

	2023	2024 (projected)
Short and Long Term Debt Total	900.0	800.0
Total Assets	226.6M	209.4M

Short Long Term Debt Total Total Assets

XBiotech balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Other Stockholder Equity	Other Liab	Retained Earnings Total Equity	Non Currrent Assets Other
Total Assets		-0.09	0.87	0.88	1.0	0.47	-0.99	0.9	0.24	0.99	0.91	0.99	0.62	0.68	0.59	0.25	0.9	0.44	1.0	0.63	0.54	0.99	0.33	0.55	0.96	0.24
Short Long Term Debt Total	-0.09		-0.01	-0.02	-0.09	-0.17	0.15	0.01	-0.13	-0.09	-0.06	-0.09	-0.23	-0.12	-0.26	0.1	-0.03	-0.29	-0.09	-0.21	-0.24	-0.14	0.07	-0.54	-0.08	0.44
Other Current Liab	0.87	-0.01		1.0	0.85	0.22	-0.89	0.84	0.08	0.9	0.91	0.88	0.4	0.9	0.19	-0.07	0.99	0.14	0.85	0.41	0.24	0.85	-0.09	0.18	0.85	0.65
Total Current Liabilities	0.88	-0.02	1.0		0.86	0.26	-0.9	0.82	0.17	0.91	0.92	0.89	0.45	0.89	0.21	-0.06	1.0	0.18	0.86	0.46	0.26	0.86	-0.08	0.2	0.85	0.63
Total Stockholder Equity	1.0	-0.09	0.85	0.86		0.48	-0.99	0.89	0.24	0.99	0.9	0.99	0.63	0.65	0.61	0.27	0.88	0.46	1.0	0.64	0.56	0.99	0.35	0.57	0.96	0.21
Property Plant And Equipment Net	0.47	-0.17	0.22	0.26	0.48		-0.42	0.07	0.6	0.42	0.61	0.43	0.92	0.24	0.53	0.24	0.29	0.92	0.45	0.93	0.87	0.42	0.35	0.52	0.25	-0.27
Net Debt	-0.99	0.15	-0.89	-0.9	-0.99	-0.42		-0.9	-0.22	-1.0	-0.91	-0.99	-0.59	-0.71	-0.57	-0.16	-0.92	-0.41	-0.99	-0.6	-0.5	-0.99	-0.28	-0.55	-0.96	-0.27
Retained Earnings	0.9	0.01	0.84	0.82	0.89	0.07	-0.9		-0.07	0.91	0.72	0.9	0.22	0.59	0.46	0.25	0.84	0.08	0.91	0.22	0.21	0.92	0.3	0.41	0.98	0.34
Accounts Payable	0.24	-0.13	0.08	0.17	0.24	0.6	-0.22	-0.07		0.21	0.31	0.22	0.63	-0.01	0.17	0.13	0.18	0.52	0.23	0.64	0.24	0.18	0.15	0.2	0.08	-0.13
Cash	0.99	-0.09	0.9	0.91	0.99	0.42	-1.0	0.91	0.21		0.91	1.0	0.59	0.7	0.57	0.17	0.92	0.41	0.99	0.59	0.49	0.99	0.28	0.53	0.96	0.3
Non Current Assets Total	0.91	-0.06	0.91	0.92	0.9	0.61	-0.91	0.72	0.31	0.91		0.91	0.71	0.84	0.38	0.06	0.93	0.5	0.89	0.73	0.58	0.88	0.08	0.37	0.8	0.41
Cash And Short Term Investments	0.99	-0.09	0.88	0.89	0.99	0.43	-0.99	0.9	0.22	1.0	0.91		0.6	0.68	0.59	0.16	0.91	0.42	0.99	0.6	0.51	0.99	0.3	0.55	0.96	0.26
Common Stock Total Equity	0.62	-0.23	0.4	0.45	0.63	0.92	-0.59	0.22	0.63	0.59	0.71	0.6		0.38	0.55	0.14	0.47	0.87	0.6	0.99	0.86	0.57	0.23	0.55	0.4	-0.15
Common Stock Shares Outstanding	0.68	-0.12	0.9	0.89	0.65	0.24	-0.71	0.59	-0.01	0.7	0.84	0.68	0.38		-0.05	-0.14	0.87	0.08	0.65	0.41	0.26	0.65	-0.33	0.02	0.62	0.68
Non Current Liabilities Total	0.59	-0.26	0.19	0.21	0.61	0.53	-0.57	0.46	0.17	0.57	0.38	0.59	0.55	-0.05		0.18	0.26	0.72	0.61	0.53	0.69	0.61	0.78	0.95	0.55	-0.54
Other Current Assets	0.25	0.1	-0.07	-0.06	0.27	0.24	-0.16	0.25	0.13	0.17	0.06	0.16	0.14	-0.14	0.18		-0.05	0.14	0.27	0.15	0.26	0.25	0.45	0.13	0.28	-0.3
Total Liab	0.9	-0.03	0.99	1.0	0.88	0.29	-0.92	0.84	0.18	0.92	0.93	0.91	0.47	0.87	0.26	-0.05		0.21	0.88	0.48	0.29	0.88	-0.04	0.24	0.87	0.6
Property Plant And Equipment Gross	0.44	-0.29	0.14	0.18	0.46	0.92	-0.41	0.08	0.52	0.41	0.5	0.42	0.87	0.08	0.72	0.14	0.21		0.43	0.85	0.88	0.42	0.46	0.7	0.25	-0.43
Total Current Assets	1.0	-0.09	0.85	0.86	1.0	0.45	-0.99	0.91	0.23	0.99	0.89	0.99	0.6	0.65	0.61	0.27	0.88	0.43		0.61	0.53	0.99	0.35	0.57	0.97	0.21
Common Stock	0.63	-0.21	0.41	0.46	0.64	0.93	-0.6	0.22	0.64	0.59	0.73	0.6	0.99	0.41	0.53	0.15	0.48	0.85	0.61		0.85	0.57	0.24	0.53	0.41	-0.12
Property Plant Equipment	0.54	-0.24	0.24	0.26	0.56	0.87	-0.5	0.21	0.24	0.49	0.58	0.51	0.86	0.26	0.69	0.26	0.29	0.88	0.53	0.85		0.52	0.38	0.67	0.36	-0.36
Net Tangible Assets	0.99	-0.14	0.85	0.86	0.99	0.42	-0.99	0.92	0.18	0.99	0.88	0.99	0.57	0.65	0.61	0.25	0.88	0.42	0.99	0.57	0.52		0.33	0.58	0.98	0.2
Other Stockholder Equity	0.33	0.07	-0.09	-0.08	0.35	0.35	-0.28	0.3	0.15	0.28	0.08	0.3	0.23	-0.33	0.78	0.45	-0.04	0.46	0.35	0.24	0.38	0.33		0.68	0.34	-0.57
Other Liab	0.55	-0.54	0.18	0.2	0.57	0.52	-0.55	0.41	0.2	0.53	0.37	0.55	0.55	0.02	0.95	0.13	0.24	0.7	0.57	0.53	0.67	0.58	0.68		0.51	-0.6
Retained Earnings Total Equity	0.96	-0.08	0.85	0.85	0.96	0.25	-0.96	0.98	0.08	0.96	0.8	0.96	0.4	0.62	0.55	0.28	0.87	0.25	0.97	0.41	0.36	0.98	0.34	0.51		0.26
Non Currrent Assets Other	0.24	0.44	0.65	0.63	0.21	-0.27	-0.27	0.34	-0.13	0.3	0.41	0.26	-0.15	0.68	-0.54	-0.3	0.6	-0.43	0.21	-0.12	-0.36	0.2	-0.57	-0.6	0.26

Click cells to compare fundamentals

XBiotech Account Relationship Matchups

XBiotech balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	816.9M	353.7M	275.2M	246.1M	226.6M	209.4M
Other Current Liab	53.5M	1.4M	1.4M	1.6M	3.5M	6.5M
Total Current Liabilities	60.2M	4.0M	3.5M	4.1M	6.1M	9.4M
Total Stockholder Equity	755.6M	348.6M	269.4M	240.4M	218.8M	199.2M
Property Plant And Equipment Net	25.2M	27.3M	28.3M	26.3M	24.9M	22.6M
Net Debt	(714.6M)	(237.4M)	(237.0M)	(157.3M)	(200.0M)	(210.0M)
Retained Earnings	430.9M	97.6M	5.2M	(27.7M)	(52.3M)	(54.9M)
Accounts Payable	2.1M	2.5M	2.1M	2.4M	2.5M	2.5M
Cash	714.6M	237.4M	237.0M	157.3M	200.0M	163.9M
Non Current Assets Total	100.6M	27.9M	28.3M	26.3M	24.9M	29.6M
Cash And Short Term Investments	714.6M	237.4M	237.0M	217.5M	200.0M	169.4M
Common Stock Total Equity	324.8M	249.8M	262.3M	267.3M	307.4M	244.1M
Common Stock Shares Outstanding	46.3M	30.8M	30.0M	30.4M	30.4M	36.4M
Liabilities And Stockholders Equity	816.9M	353.7M	275.2M	246.1M	226.6M	209.4M
Non Current Liabilities Total	1.1M	1.1M	2.3M	1.6M	1.7M	870.2K
Other Current Assets	1.7M	84.4M	934K	601K	760K	722K
Total Liab	61.2M	5.1M	5.8M	5.7M	7.8M	10.2M
Property Plant And Equipment Gross	25.2M	27.3M	44.0M	26.3M	43.1M	25.8M
Total Current Assets	716.3M	325.9M	246.9M	219.8M	201.7M	179.8M
Accumulated Other Comprehensive Income	(255K)	(106K)	1.3M	2.0M	826K	0.0
Common Stock	324.8M	249.8M	262.3M	267.3M	271.2M	248.6M
Property Plant Equipment	25.2M	27.3M	28.3M	26.3M	30.2M	20.6M
Net Tangible Assets	755.6M	348.6M	269.4M	240.4M	276.5M	236.7M
Other Stockholder Equity	(255K)	(106K)	1.3M	2.0M	826K	0.0
Other Liab	1.1M	1.1M	2.3M	1.6M	1.9M	2.0M
Retained Earnings Total Equity	430.9M	97.6M	5.2M	(27.7M)	(31.9M)	(33.5M)
Non Currrent Assets Other	27.3M	75M	(1.1M)	(1.7M)	(1.5M)	(1.4M)
Net Invested Capital	755.6M	348.6M	269.4M	240.4M	218.8M	304.0M
Net Working Capital	656.1M	321.9M	243.4M	215.8M	195.6M	263.6M
Capital Stock	324.8M	249.8M	262.3M	267.3M	271.2M	220.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for XBiotech Stock Analysis

When running XBiotech's price analysis, check to measure XBiotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XBiotech is operating at the current time. Most of XBiotech's value examination focuses on studying past and present price action to predict the probability of XBiotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XBiotech's price. Additionally, you may evaluate how the addition of XBiotech to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

XBiotech Historical Balance Sheet

XBiotech Inventory

(7.65 Million)

About XBiotech Balance Sheet Analysis

XBiotech Balance Sheet Chart

Total Assets

Total Liab

Long Term Debt

Additional Paid In Capital

XBiotech balance sheet Correlations

XBiotech Account Relationship Matchups

High Positive Relationship

High Negative Relationship

XBiotech balance sheet Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for XBiotech Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Current Liabilities	+ 1.0	Other Current Liab
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash

Cash	- 1.0	Net Debt
Net Tangible Assets	- 0.99	Net Debt
Total Current Assets	- 0.99	Net Debt
Cash And Short Term Investments	- 0.99	Net Debt
Net Debt	- 0.99	Total Stockholder Equity
Net Debt	- 0.99	Total Assets